Clinical Trial Update: Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effectiveness of interventional therapy for non-flow-limiting vulnerable plaques in the coronary arteries, currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques | Phase 4 | Status: RECRUITING